Delivery Order SPE2DB20D2014-SPE2DB24FC73Y

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,265.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of September 13, 2024. This is a firm-fixed-price delivery order contract, which indicates that Amerisourcebergen will provide the specified medical product at a predetermined price. Amerisourcebergen is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $17,420.01 firm-fixed-price delivery order is for the supply of MENVEO 1 vial-A-C-Y-W-135-DIP 0.5ML pharmaceutical products, with an ultimate completion date of August 14, 2024. There is no set-aside designation for this contract. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the U.S. government, holds several...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, over a period ending on June 28, 2024. The award has a ceiling value of $1,173.53 and is a firm fixed-price delivery order contract. The contract was awarded without any set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,119.68 firm-fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccination product, with an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop...
This federal contract award, valued at $11,255.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price contract. The award is not designated as a set-aside contract, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,431.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a performance period ending on April 8, 2025. The...
This federal contract award, valued at $4,091.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract involves the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of September 11, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, with a ceiling value of $22,154.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order contract for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 18, 2024 and was awarded on September 17, 2024. This contract is not set aside for any specific business type. Amerisourcebergen is a major supplier...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The firm-fixed-price Delivery Order has a ceiling value of $1,322.30 and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this critical medical commodity to support federal healthcare programs and military treatment facilities. The contract is...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,224.50 firm fixed-price delivery order is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a completion date of June 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which allows Amerisourcebergen to supply a wide range of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC73Y
    Delivery Order

This federal contract award, valued at $1,826.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

The specific item being procured is MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This contract award does not have a set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will be responsible for delivering the requested item by the ultimate completion date of August 14, 2024.

Generated 11/12/24, 9:07 AM